Cargando…
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Autores principales: | Berres, Marie-Luise, Lim, Karen Phaik Har, Peters, Tricia, Price, Jeremy, Takizawa, Hitoshi, Salmon, Hélène, Idoyaga, Juliana, Ruzo, Albert, Lupo, Philip J., Hicks, M. John, Shih, Albert, Simko, Stephen J., Abhyankar, Harshal, Chakraborty, Rikhia, Leboeuf, Marylene, Beltrão, Monique, Lira, Sérgio A., Heym, Kenneth M., Clausen, Björn E., Bigley, Venetia, Collin, Matthew, Manz, Markus G., McClain, Kenneth, Merad, Miriam, Allen, Carl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322054/ https://www.ncbi.nlm.nih.gov/pubmed/25646268 http://dx.doi.org/10.1084/jem.2013097701202015c |
Ejemplares similares
-
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
por: Berres, Marie-Luise, et al.
Publicado: (2014) -
RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions
por: Hogstad, Brandon, et al.
Publicado: (2018) -
Hepatic Langerhans Cell Histiocytosis (LCH) Presenting as a Harbinger of Multisystem LCH
por: Li, Hua, et al.
Publicado: (2020) -
Light Composite Higgs: LCH@LHC
por: Sannino, F
Publicado: (2005) -
Salvage treatment of relapsed/refractory LCH
por: Seo, Jong Jin
Publicado: (2016)